Nana is an experienced Molecular genomics sales specialist. Deep understanding of gene expression and NGS technologies in Life sciences, Biopharma discovery/development and clinical diagnostic settings. Consistently successful with high value capital equipment and end-to-end solutions sales. Nana is Specialised in enabling new technologies into research, Pharma/Biotech, translational and clinical accounts. Held role leading strategic pharmaceutical gene expression relationships in biomarker development/discovery research.
Nana’s most recent role comprises leading clinical oncology market development in UK and Ireland. Travelling frequently to strategic NHS laboratory hub leaders to develop faster, coordinated, multi-laboratory validation and technology adoption.

Ramin is a Molecular Biologist by training (PhD from Paris University) and has 25 years experience of commercialization of innovative products and services in Genomics and MDx products in Europe.
In a previous life, Ramin has had positions as International Business Development Director at and Channel Distribution Director at GE, NEN (now PE), Kodak and Affymetrix (now Thermo Fisher) . In 2006 he co-founded and managed a BD consulting firm dedicated to innovative tools and services start-ups. Since 2018 he has set up Moovnscope to provide BD As A Service to Start-ups in Genomics, Biomarker Discovery and MDx .
Over the past 15 years, Ramin has led Sales, Marketing and BD projects for more than 150 start-ups and SMEs in Europe. Ramin has a passion for photography and is a football fan.

Engelbert is a Biologist with more than 25 years of experience in business development and sales of products and services in the life science industry, focus on genomics and personalized medicine. In-depth market knowledge and extensive networks in clinical research, biomarker development and Molecular diagnostics. Engelbert has founded and directed multiple start-ups including Medigenomix (prior to it sales to Eurofins) and has a depth of knowledge in identifying and implementing new business opportunities in Central Europe.